 Connection
Matthew Daley to Vaccines, Conjugate
This is a "connection" page, showing publications Matthew Daley has written about Vaccines, Conjugate.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.139 |
|
|
|
-
Daley MF, Crane LA, Beaty BL, Barrow J, Pearson K, Stevenson JM, Berman S, Kempe A. Provider adoption of pneumococcal conjugate vaccine and the impact of vaccine shortages. Ambul Pediatr. 2005 May-Jun; 5(3):157-64.
Score: 0.061
-
Kamidani S, Panagiotakopoulos L, Licata C, Daley MF, Yih WK, Zerbo O, Tseng HF, DeSilva MB, Nelson JC, Groom HC, Williams JTB, Hambidge SJ, Donahue JG, Belay ED, Weintraub ES. Kawasaki Disease Following the 13-valent Pneumococcal Conjugate Vaccine and Rotavirus Vaccines. Pediatrics. 2022 12 01; 150(6).
Score: 0.052
-
Nelson JC, Yu O, Dominguez-Islas CP, Cook AJ, Peterson D, Greene SK, Yih WK, Daley MF, Jacobsen SJ, Klein NP, Weintraub ES, Broder KR, Jackson LA. Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety study. Am J Epidemiol. 2013 Jan 15; 177(2):131-41.
Score: 0.026
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|